1281:: "In the event of interlocutory revision (...), the department of the first instance whose decision has been appealed is not competent to refuse a request of the appellant for reimbursement of the appeal fee"; composition of the competent Board of Appeal to decide upon whether a reimbursement is justified in the event that the first instance departement does not grant a request for reimbursement: "The board of appeal which would have been competent (...) to deal with the substantive issues of the appeal if no interlocutory revision had been granted is competent to decide on the request."
2109:. More precisely: "A European patent application can be refused under Articles 97(2) and 125 EPC if it claims the same subject-matter as a European patent which has been granted to the same applicant and does not form part of the state of the art pursuant to Article 54(2) and (3) EPC." The referral does not expressly deal, however, with the question as to (i) what "the same subject-matter" exactly means, (ii) what "the same applicant" exactly means, and (iii) whether the prohibition of double patenting also applies during
940:, submissions by an accompanying person cannot be made as a matter of right, but only with the permission of and at the discretion of the EPO (i.e., under the discretion of the Opposition Division or the Board of Appeal). The submissions by the accompanying person must be made under the continuing responsibility and control of the professional representative. This also applies to oral submissions by "qualified patent lawyers of countries which are not contracting states to the EPC."
1212:, i.e. allowability of disclaimers despite the absence of basis for the disclaimer in the application as filed. "An amendment to a claim by the introduction of a disclaimer may not be refused under Art. 123(2) EPC 1973 for the sole reason that neither the disclaimer nor the subject-matter excluded by it from the scope of the claim have a basis in the application as filed".
1720:) in opposition proceedings: "In considering whether, for the purposes of Article 101(3) EPC, a patent as amended meets the requirements of the EPC, the claims of the patent may be examined for compliance with the requirements of Article 84 EPC only when, and then only to the extent that the amendment introduces non-compliance with Article 84 EPC."
1122:, the designation of a Contracting State does not retroactively lose effect if the designation fee has not been paid on time. Also, the deemed withdrawal of a designation takes effect upon expiry of the time limits in Article 79(2) and Rules 15(2), 25(2) and 107(1) 1973 EPC as appropriate (and not on expiry grace period for delayed post).
1049:
taken into consideration. III. The exception to patentability in
Article 53(b), first half-sentence, EPC applies to plant varieties irrespective of the way in which they were produced. Therefore, plant varieties containing genes introduced into an ancestral plant by recombinant gene technology are excluded from patentability."
3315:
1858:
Partial priority. "The questions referred to clarify how
Article 88(2), second sentence, EPC is to be applied in the light of the Enlarged Board's decision G 2/98 in cases where a claim encompasses, without spelling them out, alternative subject-matters having all the features of the claim (known as
1002:
It is admissible to file an opposition on behalf of third party (the "principal"), i.e. it is admissible to act as a straw man when filing an opposition. The principal can under no circumstances be regarded as a party to the proceedings. The straw man opponent has the status of opponent. Exception if
697:
In principle, the
Opposition Division shall examine only such grounds for opposition which have been properly submitted and substantiated in accordance with Article 99(1) in conjunction with Rule 55(c) EPC. Exceptionally, the Opposition Division may in application of Article 114(1) EPC consider other
1919:
The
President of the EPO referred the following question to the Enlarged Board of Appeal: "If notice of appeal is filed and/or the appeal fee is paid after expiry of the two month time limit under Article 108 EPC, is the appeal inadmissible or is it deemed not to have been filed, and must the appeal
1334:
representing the deductive medical or veterinary decision phase as a purely intellectual exercise", (ii) the preceding constitutive steps for making the diagnosis, and (iii) "the specific interactions with the human or animal body which occur when carrying those out among these preceding steps which
664:
in doubt on the basis of already available information." (Underlining in the original; notes within brackets added). If an opponent deliberately limits "the extent to which the patent is opposed to only certain subject-matters", these "subject-matters are therefore, strictly speaking, not subject to
1866:
against one another in respect of subject-matter disclosed in a priority application but not entitled to priority." The order reads: "Under the EPC, entitlement to partial priority may not be refused for a claim encompassing alternative subject-matter by virtue of one or more generic expressions or
1048:
Headnote: "I. A claim wherein specific plant varieties are not individually claimed is not excluded from patentability under
Article 53(b) EPC even though it may embrace plant varieties. II. When a claim to a process for the production of a plant variety is examined, Article 64(2) EPC is not to be
652:
Framework of opposition and appeal, insofar as the extent of the opposition is concerned: "The power of an
Opposition Division or a Board of Appeal to examine and decide on the maintenance of a European patent under Articles 101 and 102 EPC depends upon the extent to which the patent is opposed in
2170:
of the claimed subject-matter: Yes, the
Enlarged Board of Appeal held that this was allowed provided that "the skilled person, having the common general knowledge in mind, and based on the application as originally filed, would derive said effect as being encompassed by the technical teaching and
1900:
The introduction of such a disclaimer may not provide a technical contribution to the subject-matter disclosed in the application as filed. In particular, it may not be or become relevant for the assessment of inventive step or for the question of sufficiency of disclosure. The disclaimer may not
540:
when a
European patent is amended during opposition proceedings. In other words, "when patent is amended in opposition proceedings, unity no longer has any relevance." Unity of invention under Article 82 EPC is merely an administrative regulation, the function of which being fulfilled during
2144:
if not all of the parties to the proceedings have given their consent to the conduct of oral proceedings in the form of a videoconference?" Answer: "During a general emergency impairing the parties' possibilities to attend in-person oral proceedings at the EPO premises, the conduct of oral
1625:
Delimitation of competence between the Legal Board of Appeal and its
Technical Boards of Appeal: A Technical Board of Appeal, rather than the Legal Board of Appeal, is competent for an appeal against a decision of an Examining Division refusing a request for refund of a search fee under
1867:
otherwise (generic "OR"-claim) provided that said alternative subject-matter has been disclosed for the first time, directly, or at least implicitly, unambiguously and in an enabling manner in the priority document. No other substantive conditions or limitations apply in this respect."
3308:
3301:
2279:
Claim construction under the EPC; use of the description and drawings under
Article 69(1), second sentence, EPC and the Protocol on the Interpretation of Article 69 EPC to interpret the claims when assessing the patentability of an invention under Articles 52 to 57 EPC
2882:
2301:
1840:
Request for a proposal of removal from Office: "Decision not to propose removal from office after threat by president of the European Patent Office to the Enlarged Board of Appeal; which the Administrative Council did not sufficiently distance itself of."
1769:
Request for a proposal of removal from Office: "Article 12a(5) RPEBA requires that the request under Article 12a(1) RPEBA specify individual incidents and the evidence for them, and give reasons why they constitute a serious ground within the meaning of
1976:, who has lodged an appeal against the decision to grant a European patent, has no right to an oral hearing before a Board of Appeal of the EPO about their request to order re-entry into the examination procedure in order to remedy allegedly unclear
2877:
1578:"if the subject-matter remaining in the claim after the introduction of the disclaimer is not, be it explicitly or implicitly, directly and unambiguously disclosed to the skilled person using common general knowledge, in the application as filed".
2145:
proceedings before the boards of appeal in the form of a videoconference is compatible with the EPC even if not all of the parties to the proceedings have given their consent to the conduct of oral proceedings in the form of a videoconference."
1670:
Opponent company ceased to exist, for all purposes, before issuance of the decision of the Opposition Division, and then restored -with retroactive effect under the governing national law- after filing the appeal. Admissibility of the appeal.
3600:
1298:
The status as an opponent cannot be freely transferred; filing of an appeal when "there is a justifiable legal uncertainty as to how the law is to be interpreted in respect of the question of who the correct party to the proceedings is".
660:. However, subject-matters of claims depending on an independent claim, which falls in opposition or appeal proceedings, may be examined as to their patentability even if they have not been explicitly opposed, provided their validity is
276:- Art. 52(4) and 54(5) EPC 1973 - No substantive distinction between method claims and use claims, allowability of second medical indications, although Art. 54(4) EPC 1973 appeared to only deal with first medical indications. (
353:
but who fails to file a statement setting out the grounds of appeal within the four-month time limit laid down in the third sentence of Article 108 EPC may apply for reestablishment of rights in respect of that failure".
2836:
763:
2261:
State of the art character (within the meaning of Article 54(2) EPC) of a product when "its composition or internal structure could not be analysed and reproduced without undue burden by the skilled person before "
1922:
The Enlarged Board, in its opinion issued in July 2019, explained that the appeal is deemed not to have been filed −and the appeal fee has to be reimbursed− in the three following cases (provisional translation): "
1515:
Following refusal of a European patent application by the Examining Division, the application remains pending until the expiry of the time limit for filing a notice of appeal, so that a divisional application under
1822:
Request for a proposal of removal from Office: "Case terminated by withdrawal of the request from the Administrative Council. Reimbursement of all respondent's procedural costs proposed, as well as publication"
2953:
1605:
for a correction of the text of a patent is inadmissible, "irrespective of whether the error was made (or introduced) by the applicant or by the Examining Division" and "independently of when it is filed".
2678:
Moufang, Rainer (2022). "Aktuelle Rechtsprechung der Beschwerdekammern des EPA : Notizen für die Praxis" [Current case law of the Boards of Appeal of the EPO : Notes for practitioners].
2177:
1933:
where the appeal fee was paid within the two‑month time limit prescribed in Article 108, first sentence, EPC for filing notice of appeal AND notice of appeal was filed after expiry of that two‑month time
71:
2091:
583:
Once an appeal is withdrawn by the sole appellant, appeal proceedings are terminated at least in so far as substantive issues are concerned. This applies to both ex parte and inter partes proceedings.
2123:
2867:
2419:
1571:
An amendment to a claim which introduces a disclaimer disclaiming subject-matter that was (positively) disclosed as an embodiment of the invention in the application as filed is not allowable under
2985:
2898:
1930:
where notice of appeal was filed after expiry of the two‑month time limit prescribed in Article 108, first sentence, EPC AND the appeal fee was paid after expiry of that two‑month time limit; and
1501:
2979:
1232:
TRIPS does not entitle an applicant to claim priority from filing in a state which was not at the relevant dates a member of the Paris Convention (but was a member of the WTO/TRIPS Agreement).
1160:
A joint opposition only requires one fee. Any appeal must be by a common representative. It must remain clear who the applicant(s)/appellant(s) are especially if one withdraws from proceedings
343:
1454:
Language of the proceedings. No change of the language of a Euro-PCT application upon entry into European phase if the language of the PCT application is already in an EPO official language.
2810:
1177:
687:
An Opposition Division or a Board of Appeal is not obliged to consider all the grounds for opposition referred to in Article 100 EPC, going beyond the grounds covered by the statement under
2003:
1942:
2938:
2846:
1028:
171:
783:
Unlawful applicant. No requirement that the earlier (usurped) European patent application be pending before the EPO for the lawful applicant to be able to file a new application under
1927:(where notice of appeal was filed within the two‑month time limit prescribed in Article 108, first sentence, EPC AND the appeal fee was paid after expiry of that two‑month time limit;
63:
1584:
562:
applies in principle also to employees of the departments of the first instance of the EPO taking part in decision-making activities affecting the rights of any party." (headnote 1)
2831:
2761:
2110:
933:
2990:
2933:
2113:. In its decision, the Enlarged Board of Appeal thus confirmed the EPO practice existing prior to the referral, and did so based on a comprehensive historical analysis of the
2167:
47:
346:
is available only to patent applicants and patent proprietors, "an opponent who files a notice of appeal within the two-month time limit laid down in the first sentence of
2841:
937:
635:, irrespective of whether or not particular reasons can be identified for analysing the composition. 2. The same principle applies mutatis mutandis to any other product."
137:
3293:
2826:
1748:). Product claims directed to plants or plant material are allowable. In other words, "plants or seeds obtained through a conventional breeding methods are patentable."
1098:, the relevant date is the date of the actual filing of the European patent application; the date of priority is not to be taken account of in calculating this period."
159:(following a referral from the President of the EPO), "to ensure uniform application of the law" and to clarify or interpret important points of law in relation to the
2973:
957:"An appeal from a decision of an Examining Division refusing a request under for correction of the decision to grant is to be decided by a technical board of Appeal."
2070:
87:
3005:
2958:
1948:
39:
3528:
3524:
3520:
1977:
1832:
1813:
1760:
1633:, when the Examining Division's decision has not been taken together with a decision granting a European patent or refusing a European patent application.
79:
2754:
121:
2283:
2137:
Question referred: "Is the conduct of oral proceedings in the form of a videoconference compatible with the right to oral proceedings as enshrined in
31:
55:
2928:
2564:
1804:
1754:
1751:
1395:
754:
The Enlarged Board decided that an opposition to a European patent by its own proprietor is not admissible, thereby overturning earlier decision
670:
1987:) of the European patent. Furthermore, such an appeal has no suspensive effect. (2) Oral proceedings before the Boards of Appeal may be held in
2603:"Opinion G 1/18 on the distinction between an appeal deemed not to have been filed and an inadmissible appeal, and on the consequences of this"
1557:
1554:
1457:
1440:
2747:
2514:
1101:
960:
796:
701:
Fresh grounds for opposition may be considered in appeal proceedings only with the approval of the patentee ." (Notes within brackets added)
1901:
remove more than necessary either to restore novelty or to disclaim subject-matter excluded from patentability for non-technical reasons."
2943:
1023:
A request to review a final decision of a Board of Appeal is not provided for in the EPC (at that time). With the entry into force of the
1523:
may be filed even after the refusal of an application until expiry of the time limit of two months for filing a notice of appeal under
2166:
not publicly available before the filing date of a patent, submitted by a patentee to prove a technical effect relied on to establish
1966:
3595:
2851:
500:
698:
grounds for opposition which, prima facie, in whole or in part would seem to prejudice the maintenance of the European patent.
114:
1886:"For the purpose of considering whether a claim amended by the introduction of an undisclosed disclaimer is allowable under
2105:
There is a legal basis in the European Patent Convention (EPC) for refusing a European patent application on the ground of
2540:"Notice from the European Patent Office dated 2 October 2015 concerning the staying of proceedings due to referral G 1/15"
1844:
1780:
2770:
2424:
2699:
2628:
2602:
2518:
2265:
2174:
2120:
1994:
2580:
2784:
2322:
2206:
2141:
2056:
2049:
2045:"lants and animals exclusively obtained by essentially biological processes are not patentable". Interpretation of
1984:
1973:
1890:
1863:
1798:
1774:
1745:
1717:
1630:
1602:
1575:
1527:
1520:
1475:
1389:
1327:
1320:
1278:
1184:
1119:
1095:
929:
787:
691:
657:
537:
530:
350:
339:
178:
167:
160:
156:
149:
22:
2500:
3346:
2918:
2539:
1951:
1656:
1003:
there is a circumvention of law by abuse of process; in such case the opposition may be rejected as inadmissible.
457:
265:
261:
257:
253:
249:
245:
241:
107:
1870:
1807:
1478:, where the second medical indication differs only from the first medical indication by the dosage regime used.
2923:
2913:
2213:
under the autonomous law of the EPC that the applicant claiming priority is indeed entitled to claim priority.
558:
Suspected partiality of a member of an Opposition Division or an Examining Division. "(...) the requirement of
491:
487:
483:
1187:- direct and unambiguous derivation from the previous application required to enjoy the claimed priority right
883:- main aim: examination of the contested decision but no ban from introducing new grounds, facts or evidence
163:, and decisions on a request for a proposal of removal from Office of a member of the Boards of Appeal under
2948:
2734:
Index of decisions and opinions of the Enlarged Board of Appeal published in the Official Journal of the EPO
2296:
2472:
2393:
2381:
2357:
2345:
2148:
1997:
1723:
1338:
1330:) if the subject-matter of a claim includes features relating to: (i) "the diagnosis for curative purposes
1284:
1235:
1218:
1215:
1190:
1163:
1146:
1125:
1052:
1034:
1009:
1006:
984:
981:
943:
886:
865:
848:
831:
828:
793:
769:
740:
723:
706:
668:
638:
613:
610:
589:
586:
565:
544:
512:
509:
506:
477:
474:
414:
391:
374:
357:
321:
301:
298:
295:
3239:
2805:
2369:
2210:
1581:
1364:
1361:
1356:
141:
2733:
2198:
Formal priority ("same applicant"): The EPO is competent to assess whether a party is entitled to claim
599:
595:
1543:
1539:
1484:
994:
990:
970:
966:
806:
802:
575:
571:
449:
445:
2333:
1905:
1674:
1653:
1636:
1609:
2995:
2000:
2727:
1826:
3098:
2965:
2085:
1209:
816:
2180:
461:
2219:
2216:
2006:
1893:, the disclaimer must fulfil one of the criteria set out in point 2.1 of the order of decision
3508:
3423:
3415:
3255:
2483:
2482:(2/2016). Institute of Professional Representatives before the European Patent Office: 43–44.
1733:
1729:
1650:
Admissibility of the appeal; identity of the appellant; alleged error and correction thereof.
1348:
1344:
1316:
Diagnostic methods practised on the human or animal body are prohibited from patentability by
1200:
1196:
631:
when the product as such is available to the public and can be analysed and reproduced by the
1859:
a generic "OR"-claim), and whether parent and divisional applications may be prior art under
871:
676:
2302:
List of successful petitions for review under Article 112a of the European Patent Convention
2271:
2253:
2190:
2186:
2154:
2106:
2097:
2037:
1911:
1876:
1786:
1705:
1446:
1308:
1290:
1266:
1224:
1152:
1131:
1107:
1083:
1040:
1015:
949:
854:
775:
729:
712:
644:
628:
619:
550:
518:
397:
380:
363:
327:
290:, the three official languages of the EPO. The four other decisions have not been published.
283:
2629:"Press Communiqué of 14 May 2020 concerning opinion G 3/19 of the Enlarged Board of Appeal"
3148:
1611:
1533:
1481:
1437:
1302:
684:
Framework of opposition and appeal, insofar as the grounds for opposition are concerned:"
287:
279:
145:(EPO) in chronological order of their date of issuance. The list includes decisions under
2581:"EPO Enlarged Board of Appeal clarifies standard for examining "undisclosed disclaimers""
1945:
3213:
3053:
3000:
2199:
2163:
1801:. Is the appeal inadmissible or not deemed to have been filed? - Inadmissible referral
1471:
Patentability of a second medical indication of a known substance or composition under
632:
1324:
688:
654:
3589:
3113:
2700:"Press Communiqué of 16 July 2021 on referral G 1/21 to the Enlarged Board of Appeal"
1988:
273:
2231:
As of 13 July 2024, two referrals are pending before the Enlarged Board of Appeal.
1382:
559:
175:
2319:
2138:
1970:
1887:
1795:
1599:
1572:
1524:
1275:
926:
534:
347:
336:
153:
146:
2434: : "Principles established in G 1/03 and G 2/03 for undisclosed disclaimers"
2203:
2053:
2046:
1981:
1860:
1771:
1742:
1714:
1627:
1517:
1472:
1386:
1317:
1181:
1116:
1092:
784:
527:
164:
3203:
3143:
1741:
Tomatoes II and Broccoli II (Biological processes for the production of plants,
2739:
3173:
3138:
3123:
2487:
1920:
fee be reimbursed?" (same point of law as referred to in G 1/14 and G 2/14).
205:
Opinion, after referral by the President of the EPO under Art. 112(1)(b) EPC
3118:
2908:
1378:
1794:
Appeal lodged and appeal fee paid after expiration of the time limit under
2515:"EPO Backs Patents On Conventional Plants: Broccoli, Tomato Cases Decided"
202:
Decision(s), after referral by a Board of Appeal under Art. 112(1)(a) EPC
3247:
3188:
3183:
3163:
3038:
2789:
2417:
Legal Research Service for the Boards of Appeal, European Patent Office,
1274:
Reimbursement of appeal fee in the event of interlocutory revision under
1024:
759:
2583:. Haar: Boards of Appeal of the European Patent Office. 18 December 2017
1884:
Allowability of undisclosed disclaimers introduced into a patent claim:
978:
Framework of opposition and appeal - Art. 100(a) - collection of grounds
3279:
3271:
3263:
3168:
3093:
3088:
3078:
3068:
3063:
3058:
3043:
3033:
3028:
3023:
2903:
2878:
Decisions of the Boards of Appeal relating to Article 52(2) and (3) EPC
1381:, non-patentability of inventions involving the use and destruction of
3601:
Case law of the Enlarged Board of Appeal of the European Patent Office
2567:, European Patent Register, European patent application No. 98203458.9
3569:
3561:
3540:
3532:
3504:
3500:
3492:
3484:
3476:
3468:
3460:
3452:
3444:
3407:
3386:
3382:
3377:
3356:
3208:
3198:
3178:
3158:
3153:
3133:
3108:
3083:
3073:
3048:
2129:
2076:
2064:
2060:
1957:
1894:
1850:
1662:
1642:
1617:
1590:
1563:
1507:
1490:
1463:
1426:
1370:
1169:
917:
837:
755:
746:
316:
307:
3193:
3128:
3103:
388:
Art. 123(3) - change of category - use claim novel by its purpose
2336:, reasons 1.3 (summarizing the case law established under G1/86).
790:. Dissenting opinion (Reasons for the Decision, points 8.1-8.9).
607:
Art. 123(2) - strictly declaratory nature of Rule 88 corrections
3297:
2743:
862:
Intervention during pending appeal proceedings - fresh grounds
278:
G 1/83, G 5/83 and G 6/83 have been published, respectively in
152:(following a referral from a Board of Appeal), opinions under
99:
Note: The above list of legal requirements is not exhaustive.
1498:
Patentability of programs for computers, referral dismissed
1091:"For the calculation of the six-month period referred to in
665:
any "opposition" in the sense of Articles 101 and 102 EPC".
193:
2652:
2650:
2233:
2017:
1685:
1406:
1246:
1063:
897:
425:
221:
3412:
Requirement for claiming priority of the "same invention"
1551:
Essentially biological processes (Tomatoes and Broccoli)
208:
Decision and opinion, in consolidated or identical cases
3545:
Right to be heard and correct venue for oral proceedings
720:
Oral proceedings - party absent - new facts or evidence
758:. The decision later led to the introduction, with the
2883:
Successful petitions for review under Article 112a EPC
2873:
Decisions and opinions of the Enlarged Board of Appeal
2171:
embodied by the same originally disclosed invention".
2443:
G 1/03 and G 2/03 (OJ 2004, 413 and 448), Headnote 1.
1938:
This applies similarly to the filing of oppositions.
1031:
of a decision of a Board of Appeal may now be filed.
737:
Art. 123(2) & (3) - conflict - inescapable trap
371:
Opposition - transfer - part of the business assets
3554:
3437:
3400:
3370:
3339:
3222:
3014:
2891:
2860:
2819:
2798:
2777:
1991:without infringing Articles 113(1) and 116(1) EPC.
2413:
2411:
2929:European Round Table on Patent Practice (EUROTAB)
3332:Incomplete collection of decisions and opinions
2728:Enlarged Board of Appeal decisions and opinions
2673:
2671:
845:Time limit for deposits of biological material
3006:Unitary patent (Switzerland and Liechtenstein)
2575:
2573:
3309:
2755:
627:"1. The chemical composition of a product is
115:
8:
2609:. Haar: European Patent Office. 18 July 2019
405:Novelty - second non-medical indication yes
2473:"Correcting the Text of a Published Patent"
2420:Case Law of the Boards of Appeal of the EPO
3489:Request to correct patent/FISHER-ROSEMOUNT
3316:
3302:
3294:
2762:
2748:
2740:
2546:. European Patent Office. 30 November 2015
814:Framework of appeal - extent (decision) -
122:
108:
17:
3325:Decisions of the Enlarged Board of Appeal
1139:Framework of appeal -extent (decision) -
823:With an indication of a minority opinion.
315:Opposition by proprietor - overturned by
170:. The list does not include decisions on
2681:Mitteilungen der deutschen Patentanwälte
2544:EPO Official Journal November 2015 (A92)
23:European patent applications and patents
3497:Non-refund of further search fees/BAUER
2312:
526:The requirement of unity of invention (
211:Decision in cases under Art. 23(1) EPC
20:
499:Filing of notice of opposition at the
136:list of decisions and opinions of the
2635:. European Patent Office. 14 May 2020
1180:- concept of "the same invention" in
764:limitation and revocation proceedings
653:the notice of opposition pursuant to
7:
2986:Standing Advisory Committee (SACEPO)
1598:A patent proprietor's request under
3574:Oral proceedings by videoconference
2452:G 2/04, OJ EPO 2005, 549, headnote
2382:G 9/91 (consolidated with G 10/91)
14:
3449:Treatment by surgery/MEDI-PHYSICS
1434:Methods for treatment by surgery
21:Legal requirements applicable to
3457:Dosage regime/ABBOTT RESPIRATORY
2785:European Patent Convention (EPC)
2513:Saez, Catherine (1 April 2015).
2086:computer-implemented simulations
2919:European Patent Institute (epi)
2269:
2251:
2184:
2152:
2127:
2095:
2074:
2035:
1955:
1909:
1874:
1848:
1830:
1811:
1784:
1758:
1727:
1703:
1660:
1640:
1615:
1588:
1561:
1537:
1505:
1488:
1461:
1444:
1424:
1368:
1342:
1306:
1288:
1264:
1222:
1194:
1167:
1150:
1129:
1105:
1081:
1038:
1013:
988:
964:
947:
915:
869:
852:
835:
800:
773:
744:
727:
710:
674:
642:
617:
593:
569:
548:
516:
481:
443:
395:
378:
361:
325:
305:
239:
210:
207:
204:
201:
925:During oral proceedings under
409:Partially identical to G 2/88.
1:
3327:of the European Patent Office
2954:Observations by third parties
2471:Petrucci, Luigi (June 2016).
2806:European Patent Office (EPO)
2771:European Patent Organisation
2024:Date of decision or opinion
1692:Date of decision or opinion
1413:Date of decision or opinion
1335:are of a technical nature".
1253:Date of decision or opinion
1208:Allowability of undisclosed
1070:Date of decision or opinion
904:Date of decision or opinion
432:Date of decision or opinion
228:Date of decision or opinion
72:Disclosure of the invention
2519:Intellectual Property Watch
3617:
2996:Unified Patent Court (UPC)
2790:Revised version (EPC 2000)
2423:(9th edition, July 2019),
533:) is not applicable under
161:European Patent Convention
32:Patentable subject-matter
3351:Second medical indication
3347:G 1/83, G 5/83 and G 6/83
2837:Limitation and revocation
2656:G 4/19, reasons 3 and 16.
2501:G 3/14, OJ EPO 2015, A102
2243:Keywords and/or comments
2027:Keywords and/or comments
1695:Keywords and/or comments
1416:Keywords and/or comments
1256:Keywords and/or comments
1073:Keywords and/or comments
907:Keywords and/or comments
541:examination proceedings.
458:Patent Cooperation Treaty
435:Keywords and/or comments
344:reestablishment of rights
231:Keywords and/or comments
56:Industrial applicability
3473:Pending application/SONY
3361:Opposition by proprietor
2924:European Patent Register
2914:European Patent Bulletin
2706:. European Patent Office
1713:Examination of clarity (
1027:on December 13, 2007, a
138:Enlarged Board of Appeal
3596:Case law lists by court
2899:Divisional applications
2297:List of patent case law
1357:Divisional applications
185:The list is incomplete.
3465:Programs for computers
3391:Representation/BOGASKY
3240:Bosnia and Herzegovina
2980:Restitutio in integrum
2811:Administrative Council
2211:rebuttable presumption
2209:. However, there is a
2111:opposition proceedings
879:Framework of appeal -
142:European Patent Office
3566:Pedestrian simulation
2736:, on the EPO web site
2360:, points 4.1 and 4.2.
2115:travaux préparatoires
1115:Without prejudice to
2730:, on the EPO website
2461:G 2/10, headnote 1a.
503:before July 1, 1989
172:petitions for review
3001:Unitary patent (EU)
2968:reformatio in peius
2847:Petition for review
1141:reformatio in peius
1029:petition for review
817:reformatio in peius
64:Unity of invention
3481:Disclaimer/SCRIPPS
2689:See section 2.1.1.
2665:G 4/19, reasons 4.
1766:17 September 2015
1512:27 September 2010
938:appeal proceedings
932:in the context of
462:unity of invention
3583:
3582:
3509:G 2/12 and G 2/13
3424:G 1/05 and G 1/06
3416:G 1/03 and G 2/03
3334:
3291:
3290:
3284:
3276:
3268:
3260:
3252:
3244:
3232:
3226:
2944:Judges' Symposium
2405:G 3/98, headnote.
2288:
2287:
2248:
2240:Date of referral
2224:
2223:
2162:Consideration of
2084:Patentability of
2032:
2011:
2010:
1881:18 December 2017
1855:29 November 2016
1819:11 February 2016
1791:19 November 2015
1700:
1679:
1678:
1667:25 November 2014
1468:19 February 2010
1451:16 February 2010
1431:15 February 2010
1421:
1400:
1399:
1375:25 November 2008
1313:16 December 2005
1261:
1240:
1239:
1078:
1057:
1056:
912:
891:
890:
876:30 November 1994
842:21 Decembre 1994
734:21 February 1994
624:18 December 1992
604:19 November 1992
496:16 November 1990
454:21 February 1990
440:
419:
418:
402:12 November 1989
385:12 November 1989
236:
215:
214:
154:Article 112(1)(b)
147:Article 112(1)(a)
132:
131:
3608:
3537:Partial priority
3330:
3318:
3311:
3304:
3295:
3282:
3274:
3266:
3258:
3250:
3242:
3230:
3224:
2991:Software patents
2960:Official Journal
2949:London Agreement
2764:
2757:
2750:
2741:
2716:
2715:
2713:
2711:
2696:
2690:
2688:
2675:
2666:
2663:
2657:
2654:
2645:
2644:
2642:
2640:
2625:
2619:
2618:
2616:
2614:
2599:
2593:
2592:
2590:
2588:
2577:
2568:
2562:
2556:
2555:
2553:
2551:
2536:
2530:
2529:
2527:
2525:
2510:
2504:
2498:
2492:
2491:
2477:
2468:
2462:
2459:
2453:
2450:
2444:
2441:
2435:
2431:
2427:
2415:
2406:
2403:
2397:
2391:
2385:
2379:
2373:
2367:
2361:
2355:
2349:
2343:
2337:
2331:
2325:
2317:
2246:
2234:
2195:10 October 2023
2107:double patenting
2030:
2018:
1698:
1686:
1548:9 December 2010
1419:
1407:
1271:28 January 2005
1259:
1247:
1157:18 February 2002
1112:27 November 2000
1076:
1064:
1045:20 December 1999
922:19 February 1996
910:
898:
859:5 November 1994
717:22 October 1993
629:state of the art
523:9 December 1991
438:
426:
270:5 December 1984
234:
222:
194:
124:
117:
110:
91:
83:
75:
67:
59:
51:
43:
35:
18:
3616:
3615:
3611:
3610:
3609:
3607:
3606:
3605:
3586:
3585:
3584:
3579:
3550:
3433:
3396:
3366:
3335:
3329:
3326:
3322:
3292:
3287:
3228:
3218:
3149:North Macedonia
3016:
3015:EPC contracting
3010:
2966:Prohibition of
2887:
2856:
2827:Grant procedure
2815:
2794:
2773:
2768:
2724:
2719:
2709:
2707:
2698:
2697:
2693:
2687:(7/8): 301–317.
2677:
2676:
2669:
2664:
2660:
2655:
2648:
2638:
2636:
2627:
2626:
2622:
2612:
2610:
2601:
2600:
2596:
2586:
2584:
2579:
2578:
2571:
2563:
2559:
2549:
2547:
2538:
2537:
2533:
2523:
2521:
2512:
2511:
2507:
2499:
2495:
2480:Epi Information
2475:
2470:
2469:
2465:
2460:
2456:
2451:
2447:
2442:
2438:
2429:
2425:
2416:
2409:
2404:
2400:
2392:
2388:
2380:
2376:
2368:
2364:
2356:
2352:
2344:
2340:
2332:
2328:
2318:
2314:
2310:
2293:
2229:
2218:
2189:
2179:
2176:
2122:
2016:
2005:
2002:
1999:
1996:
1950:
1947:
1944:
1806:
1753:
1732:
1684:
1655:
1583:
1568:30 August 2011
1556:
1542:
1483:
1439:
1405:
1363:
1347:
1245:
1217:
1199:
1136:4 February 2001
1062:
1020:12 October 1999
1008:
993:
983:
969:
896:
830:
820:
805:
795:
612:
598:
588:
574:
511:
508:
490:
486:
476:
448:
424:
406:
300:
297:
264:
260:
256:
252:
248:
244:
220:
192:
128:
89:
81:
73:
65:
57:
49:
48:Inventive step
41:
33:
12:
11:
5:
3614:
3612:
3604:
3603:
3598:
3588:
3587:
3581:
3580:
3578:
3577:
3558:
3556:
3552:
3551:
3549:
3548:
3441:
3439:
3435:
3434:
3432:
3431:
3404:
3402:
3398:
3397:
3395:
3394:
3380:
3374:
3372:
3368:
3367:
3365:
3364:
3354:
3343:
3341:
3337:
3336:
3323:
3321:
3320:
3313:
3306:
3298:
3289:
3288:
3286:
3285:
3277:
3269:
3261:
3253:
3245:
3236:
3234:
3220:
3219:
3217:
3216:
3214:United Kingdom
3211:
3206:
3201:
3196:
3191:
3186:
3181:
3176:
3171:
3166:
3161:
3156:
3151:
3146:
3141:
3136:
3131:
3126:
3121:
3116:
3111:
3106:
3101:
3096:
3091:
3086:
3081:
3076:
3071:
3066:
3061:
3056:
3054:Czech Republic
3051:
3046:
3041:
3036:
3031:
3026:
3020:
3018:
3012:
3011:
3009:
3008:
3003:
2998:
2993:
2988:
2983:
2976:
2974:Representation
2971:
2963:
2956:
2951:
2946:
2941:
2936:
2931:
2926:
2921:
2916:
2911:
2906:
2901:
2895:
2893:
2892:Related topics
2889:
2888:
2886:
2885:
2880:
2875:
2870:
2864:
2862:
2858:
2857:
2855:
2854:
2849:
2844:
2839:
2834:
2829:
2823:
2821:
2817:
2816:
2814:
2813:
2808:
2802:
2800:
2796:
2795:
2793:
2792:
2787:
2781:
2779:
2778:Founding texts
2775:
2774:
2769:
2767:
2766:
2759:
2752:
2744:
2738:
2737:
2731:
2723:
2722:External links
2720:
2718:
2717:
2691:
2667:
2658:
2646:
2620:
2594:
2569:
2557:
2531:
2505:
2493:
2463:
2454:
2445:
2436:
2407:
2398:
2386:
2374:
2362:
2350:
2338:
2326:
2320:Article 112(1)
2311:
2309:
2306:
2305:
2304:
2299:
2292:
2289:
2286:
2285:
2281:
2277:
2274:
2268:
2267:
2263:
2259:
2256:
2250:
2249:
2244:
2241:
2238:
2228:
2225:
2222:
2221:
2214:
2196:
2193:
2183:
2182:
2172:
2168:inventive step
2160:
2159:23 March 2023
2157:
2151:
2150:
2146:
2139:Article 116(1)
2135:
2132:
2126:
2125:
2118:
2103:
2100:
2094:
2093:
2089:
2082:
2081:10 March 2021
2079:
2073:
2072:
2068:
2059:. Overturning
2043:
2040:
2034:
2033:
2028:
2025:
2022:
2015:
2012:
2009:
2008:
1992:
1963:
1960:
1954:
1953:
1940:
1936:
1935:
1931:
1928:
1917:
1914:
1908:
1907:
1903:
1888:Article 123(2)
1882:
1879:
1873:
1872:
1868:
1856:
1853:
1847:
1846:
1842:
1838:
1835:
1829:
1828:
1824:
1820:
1817:
1810:
1809:
1802:
1796:Article 108(1)
1792:
1789:
1783:
1782:
1778:
1767:
1764:
1757:
1756:
1749:
1739:
1738:25 March 2015
1736:
1726:
1725:
1721:
1711:
1710:24 March 2015
1708:
1702:
1701:
1696:
1693:
1690:
1683:
1680:
1677:
1676:
1672:
1668:
1665:
1659:
1658:
1651:
1648:
1647:30 April 2014
1645:
1639:
1638:
1634:
1623:
1622:19 March 2014
1620:
1614:
1613:
1607:
1596:
1593:
1587:
1586:
1579:
1573:Article 123(2)
1569:
1566:
1560:
1559:
1552:
1549:
1546:
1536:
1535:
1531:
1513:
1510:
1504:
1503:
1499:
1496:
1493:
1487:
1486:
1479:
1469:
1466:
1460:
1459:
1455:
1452:
1449:
1443:
1442:
1435:
1432:
1429:
1423:
1422:
1417:
1414:
1411:
1404:
1401:
1398:
1397:
1393:
1376:
1373:
1367:
1366:
1359:
1354:
1351:
1341:
1340:
1336:
1314:
1311:
1305:
1304:
1300:
1296:
1293:
1287:
1286:
1282:
1276:Article 109(1)
1272:
1269:
1263:
1262:
1257:
1254:
1251:
1244:
1241:
1238:
1237:
1233:
1230:
1227:
1221:
1220:
1213:
1206:
1203:
1193:
1192:
1188:
1175:
1172:
1166:
1165:
1161:
1158:
1155:
1149:
1148:
1144:
1137:
1134:
1128:
1127:
1123:
1113:
1110:
1104:
1103:
1099:
1089:
1086:
1080:
1079:
1074:
1071:
1068:
1061:
1058:
1055:
1054:
1050:
1046:
1043:
1037:
1036:
1032:
1021:
1018:
1012:
1011:
1004:
1000:
999:2 January 1999
997:
987:
986:
979:
976:
973:
963:
962:
958:
955:
952:
946:
945:
941:
936:or opposition
923:
920:
914:
913:
908:
905:
902:
895:
892:
889:
888:
884:
877:
874:
868:
867:
863:
860:
857:
851:
850:
846:
843:
840:
834:
833:
826:
812:
809:
799:
798:
791:
781:
778:
772:
771:
767:
752:
749:
743:
742:
738:
735:
732:
726:
725:
721:
718:
715:
709:
708:
704:
703:
702:
699:
695:
682:
681:31 March 1993
679:
673:
672:
666:
650:
649:31 March 1993
647:
641:
640:
636:
633:skilled person
625:
622:
616:
615:
608:
605:
602:
592:
591:
584:
581:
578:
568:
567:
563:
556:
553:
547:
546:
542:
535:Article 102(3)
524:
521:
515:
514:
504:
497:
494:
480:
479:
472:
455:
452:
442:
441:
436:
433:
430:
423:
420:
417:
416:
412:
403:
400:
394:
393:
389:
386:
383:
377:
376:
372:
369:
368:24 April 1989
366:
360:
359:
355:
337:Article 122(1)
333:
330:
324:
323:
319:
313:
310:
304:
303:
293:
271:
268:
238:
237:
232:
229:
226:
219:
216:
213:
212:
209:
206:
203:
200:
191:
188:
130:
129:
127:
126:
119:
112:
104:
101:
100:
96:
95:
94:
93:
85:
77:
69:
61:
53:
45:
37:
26:
25:
13:
10:
9:
6:
4:
3:
2:
3613:
3602:
3599:
3597:
3594:
3593:
3591:
3575:
3571:
3567:
3563:
3560:
3559:
3557:
3553:
3546:
3542:
3538:
3534:
3530:
3526:
3522:
3518:
3514:
3510:
3506:
3502:
3498:
3494:
3490:
3486:
3482:
3478:
3474:
3470:
3466:
3462:
3458:
3454:
3450:
3446:
3443:
3442:
3440:
3436:
3429:
3425:
3421:
3417:
3413:
3409:
3406:
3405:
3403:
3399:
3392:
3388:
3384:
3381:
3379:
3376:
3375:
3373:
3369:
3362:
3358:
3355:
3352:
3348:
3345:
3344:
3342:
3338:
3333:
3328:
3319:
3314:
3312:
3307:
3305:
3300:
3299:
3296:
3281:
3278:
3273:
3270:
3265:
3262:
3257:
3254:
3249:
3246:
3241:
3238:
3237:
3235:
3221:
3215:
3212:
3210:
3207:
3205:
3202:
3200:
3197:
3195:
3192:
3190:
3187:
3185:
3182:
3180:
3177:
3175:
3172:
3170:
3167:
3165:
3162:
3160:
3157:
3155:
3152:
3150:
3147:
3145:
3142:
3140:
3137:
3135:
3132:
3130:
3127:
3125:
3122:
3120:
3117:
3115:
3114:Liechtenstein
3112:
3110:
3107:
3105:
3102:
3100:
3097:
3095:
3092:
3090:
3087:
3085:
3082:
3080:
3077:
3075:
3072:
3070:
3067:
3065:
3062:
3060:
3057:
3055:
3052:
3050:
3047:
3045:
3042:
3040:
3037:
3035:
3032:
3030:
3027:
3025:
3022:
3021:
3019:
3013:
3007:
3004:
3002:
2999:
2997:
2994:
2992:
2989:
2987:
2984:
2982:
2981:
2977:
2975:
2972:
2970:
2969:
2964:
2962:
2961:
2957:
2955:
2952:
2950:
2947:
2945:
2942:
2940:
2937:
2935:
2932:
2930:
2927:
2925:
2922:
2920:
2917:
2915:
2912:
2910:
2907:
2905:
2902:
2900:
2897:
2896:
2894:
2890:
2884:
2881:
2879:
2876:
2874:
2871:
2869:
2868:Case Law book
2866:
2865:
2863:
2859:
2853:
2850:
2848:
2845:
2843:
2840:
2838:
2835:
2833:
2830:
2828:
2825:
2824:
2822:
2818:
2812:
2809:
2807:
2804:
2803:
2801:
2797:
2791:
2788:
2786:
2783:
2782:
2780:
2776:
2772:
2765:
2760:
2758:
2753:
2751:
2746:
2745:
2742:
2735:
2732:
2729:
2726:
2725:
2721:
2705:
2701:
2695:
2692:
2686:
2683:(in German).
2682:
2674:
2672:
2668:
2662:
2659:
2653:
2651:
2647:
2634:
2630:
2624:
2621:
2608:
2604:
2598:
2595:
2582:
2576:
2574:
2570:
2566:
2561:
2558:
2545:
2541:
2535:
2532:
2520:
2516:
2509:
2506:
2502:
2497:
2494:
2489:
2485:
2481:
2474:
2467:
2464:
2458:
2455:
2449:
2446:
2440:
2437:
2433:
2422:
2421:
2414:
2412:
2408:
2402:
2399:
2395:
2390:
2387:
2383:
2378:
2375:
2371:
2366:
2363:
2359:
2354:
2351:
2347:
2342:
2339:
2335:
2330:
2327:
2324:
2321:
2316:
2313:
2307:
2303:
2300:
2298:
2295:
2294:
2290:
2284:
2282:
2278:
2276:24 June 2024
2275:
2273:
2270:
2266:
2264:
2260:
2258:27 June 2023
2257:
2255:
2252:
2245:
2242:
2239:
2236:
2235:
2232:
2227:Pending cases
2226:
2220:
2217:
2215:
2212:
2208:
2205:
2204:Article 87(1)
2201:
2197:
2194:
2192:
2188:
2185:
2181:
2178:
2175:
2173:
2169:
2165:
2161:
2158:
2156:
2153:
2149:
2147:
2143:
2140:
2136:
2134:16 July 2021
2133:
2131:
2128:
2124:
2121:
2119:
2116:
2112:
2108:
2104:
2102:22 June 2021
2101:
2099:
2096:
2092:
2090:
2087:
2083:
2080:
2078:
2075:
2071:
2069:
2066:
2062:
2058:
2055:
2051:
2048:
2047:Article 53(b)
2044:
2041:
2039:
2036:
2029:
2026:
2023:
2020:
2019:
2013:
2007:
2004:
2001:
1998:
1995:
1993:
1990:
1986:
1983:
1979:
1978:patent claims
1975:
1972:
1968:
1964:
1962:16 July 2019
1961:
1959:
1956:
1952:
1949:
1946:
1943:
1941:
1939:
1932:
1929:
1926:
1925:
1924:
1918:
1915:
1913:
1910:
1906:
1904:
1902:
1898:
1896:
1892:
1889:
1883:
1880:
1878:
1875:
1871:
1869:
1865:
1862:
1861:Article 54(3)
1857:
1854:
1852:
1849:
1845:
1843:
1839:
1837:14 June 2016
1836:
1834:
1831:
1827:
1825:
1821:
1818:
1815:
1812:
1808:
1805:
1803:
1800:
1797:
1793:
1790:
1788:
1785:
1781:
1779:
1776:
1773:
1772:Article 23(1)
1768:
1765:
1762:
1759:
1755:
1752:
1750:
1747:
1744:
1743:Article 53(b)
1740:
1737:
1735:
1731:
1728:
1724:
1722:
1719:
1716:
1712:
1709:
1707:
1704:
1697:
1694:
1691:
1688:
1687:
1681:
1675:
1673:
1669:
1666:
1664:
1661:
1657:
1654:
1652:
1649:
1646:
1644:
1641:
1637:
1635:
1632:
1629:
1624:
1621:
1619:
1616:
1612:
1610:
1608:
1604:
1601:
1597:
1595:23 July 2012
1594:
1592:
1589:
1585:
1582:
1580:
1577:
1574:
1570:
1567:
1565:
1562:
1558:
1555:
1553:
1550:
1547:
1545:
1541:
1538:
1534:
1532:
1529:
1526:
1522:
1519:
1514:
1511:
1509:
1506:
1502:
1500:
1497:
1494:
1492:
1489:
1485:
1482:
1480:
1477:
1474:
1473:Article 54(5)
1470:
1467:
1465:
1462:
1458:
1456:
1453:
1450:
1448:
1445:
1441:
1438:
1436:
1433:
1430:
1428:
1425:
1418:
1415:
1412:
1409:
1408:
1402:
1396:
1394:
1391:
1388:
1384:
1383:human embryos
1380:
1377:
1374:
1372:
1369:
1365:
1362:
1360:
1358:
1355:
1353:28 June 2007
1352:
1350:
1346:
1343:
1339:
1337:
1333:
1332:stricto sensu
1329:
1326:
1325:Article 52(4)
1322:
1319:
1318:Article 53(c)
1315:
1312:
1310:
1307:
1303:
1301:
1297:
1294:
1292:
1289:
1285:
1283:
1280:
1277:
1273:
1270:
1268:
1265:
1258:
1255:
1252:
1249:
1248:
1242:
1236:
1234:
1231:
1229:26 April 2004
1228:
1226:
1223:
1219:
1216:
1214:
1211:
1207:
1204:
1202:
1198:
1195:
1191:
1189:
1186:
1183:
1182:Article 87(1)
1179:
1176:
1173:
1171:
1168:
1164:
1162:
1159:
1156:
1154:
1151:
1147:
1145:
1142:
1138:
1135:
1133:
1130:
1126:
1124:
1121:
1118:
1117:Article 67(4)
1114:
1111:
1109:
1106:
1102:
1100:
1097:
1094:
1093:Article 55(1)
1090:
1087:
1085:
1082:
1075:
1072:
1069:
1066:
1065:
1059:
1053:
1051:
1047:
1044:
1042:
1039:
1035:
1033:
1030:
1026:
1022:
1019:
1017:
1014:
1010:
1007:
1005:
1001:
998:
996:
992:
989:
985:
982:
980:
977:
974:
972:
968:
965:
961:
959:
956:
954:16 April 1996
953:
951:
948:
944:
942:
939:
935:
931:
928:
924:
921:
919:
916:
909:
906:
903:
900:
899:
893:
887:
885:
882:
878:
875:
873:
870:
866:
864:
861:
858:
856:
853:
849:
847:
844:
841:
839:
836:
832:
829:
827:
824:
819:
818:
813:
811:14 July 1994
810:
808:
804:
801:
797:
794:
792:
789:
786:
785:Article 61(1)
782:
780:13 June 1994
779:
777:
774:
770:
768:
765:
761:
757:
753:
750:
748:
745:
741:
739:
736:
733:
731:
728:
724:
722:
719:
716:
714:
711:
707:
705:
700:
696:
693:
690:
686:
685:
683:
680:
678:
675:
671:
669:
667:
663:
659:
656:
651:
648:
646:
643:
639:
637:
634:
630:
626:
623:
621:
618:
614:
611:
609:
606:
603:
601:
597:
594:
590:
587:
585:
582:
579:
577:
573:
570:
566:
564:
561:
557:
554:
552:
549:
545:
543:
539:
536:
532:
529:
525:
522:
520:
517:
513:
510:
507:
505:
502:
498:
495:
493:
489:
485:
482:
478:
475:
473:
471:
467:
463:
459:
456:
453:
451:
447:
444:
437:
434:
431:
428:
427:
421:
415:
413:
410:
404:
401:
399:
396:
392:
390:
387:
384:
382:
379:
375:
373:
370:
367:
365:
362:
358:
356:
352:
349:
345:
342:implies that
341:
338:
334:
332:24 June 1987
331:
329:
326:
322:
320:
318:
314:
312:24 July 1985
311:
309:
306:
302:
299:
296:
294:
291:
289:
285:
281:
275:
274:Patentability
272:
269:
267:
263:
259:
255:
251:
247:
243:
240:
233:
230:
227:
224:
223:
217:
199:
196:
195:
190:Decided cases
189:
187:
186:
182:
180:
177:
173:
169:
166:
165:Article 23(1)
162:
158:
155:
151:
148:
144:
143:
139:
125:
120:
118:
113:
111:
106:
105:
103:
102:
98:
97:
92:
90:(Article 123)
86:
84:
78:
76:
70:
68:
62:
60:
54:
52:
46:
44:
38:
36:
30:
29:
28:
27:
24:
19:
16:
3573:
3565:
3544:
3536:
3529:Art. 23 1/16
3525:Art. 23 2/15
3521:Art. 23 1/15
3516:
3512:
3496:
3488:
3480:
3472:
3464:
3456:
3448:
3427:
3419:
3411:
3390:
3360:
3350:
3331:
3324:
2978:
2967:
2959:
2872:
2708:. Retrieved
2703:
2694:
2684:
2680:
2661:
2637:. Retrieved
2632:
2623:
2611:. Retrieved
2606:
2597:
2585:. Retrieved
2565:G 1/15 Order
2560:
2548:. Retrieved
2543:
2534:
2522:. Retrieved
2508:
2496:
2479:
2466:
2457:
2448:
2439:
2418:
2401:
2389:
2377:
2365:
2353:
2348:, point 5.2.
2341:
2329:
2315:
2230:
2117:of the EPC.
2114:
2042:14 May 2020
1937:
1921:
1899:
1885:
1833:Art. 23 1/16
1816:(G 2302/15)
1814:Art. 23 2/15
1763:(G 2301/15)
1761:Art. 23 1/15
1495:12 May 2010
1331:
1295:25 May 2005
1205:8 April 2004
1140:
1088:12 July 2000
975:19 July 1996
880:
822:
815:
751:7 June 1994
661:
580:11 May 1992
560:impartiality
470:a posteriori
469:
465:
408:
277:
197:
184:
183:
176:Article 112a
135:
133:
82:(Article 84)
74:(Article 83)
66:(Article 82)
58:(Article 57)
50:(Article 56)
42:(Article 54)
34:(Article 52)
15:
3555:2020 – 2029
3517:Broccoli II
3513:Tomatoes II
3438:2010 – 2019
3401:2000 – 2009
3371:1990 – 1999
3340:1980 – 1989
3229:validation
3204:Switzerland
3144:Netherlands
2852:Enforcement
2704:www.epo.org
2607:www.epo.org
2587:31 December
2550:30 December
2384:, point 18.
2372:, point 10.
1971:Article 115
1967:third party
1682:2015 – 2019
1525:Article 108
1403:2010 – 2014
1243:2005 – 2009
1210:disclaimers
1174:31 May 2001
1143:- exception
1060:2000 – 2004
927:Article 116
894:1995 – 1999
662:prima facie
555:5 May 1992
422:1990 – 1994
348:Article 108
218:1980 – 1989
88:Amendments
3590:Categories
3428:Divisional
3420:Disclaimer
3223:Extension
3174:San Marino
3139:Montenegro
3124:Luxembourg
2939:Guidelines
2832:Opposition
2396:, Opinion.
2308:References
2237:Reference
2054:Rule 28(2)
2021:Reference
1982:Article 84
1916:July 2019
1715:Article 84
1689:Reference
1628:Rule 64(2)
1518:Article 76
1410:Reference
1387:Rule 28(c)
1379:Stem cells
1323:(formerly
1250:Reference
1067:Reference
934:opposition
901:Reference
689:Rule 55(c)
655:Rule 55(c)
528:Article 82
429:Reference
225:Reference
134:This is a
3119:Lithuania
2909:Espacenet
2820:Procedure
2488:1434-8853
2334:T 1171/13
2014:From 2020
762:, of the
335:Although
3248:Cambodia
3189:Slovenia
3184:Slovakia
3164:Portugal
3039:Bulgaria
2861:Case law
2432:.1.7.2.a
2291:See also
2200:priority
2164:evidence
1600:Rule 140
1328:EPC 1973
1178:Priority
1025:EPC 2000
881:ex parte
760:EPC 2000
692:EPC 1973
658:EPC 1973
466:a priori
40:Novelty
3280:Tunisia
3272:Morocco
3264:Moldova
3256:Georgia
3169:Romania
3099:Ireland
3094:Iceland
3089:Hungary
3079:Germany
3069:Finland
3064:Estonia
3059:Denmark
3044:Croatia
3034:Belgium
3029:Austria
3024:Albania
2904:epoline
2710:17 July
2633:epo.org
2613:20 July
2524:6 April
2503:, Order
2394:G 10/91
2247:Sources
2031:Sources
1934:limit."
1699:Sources
1420:Sources
1260:Sources
1077:Sources
911:Sources
872:G 10/93
677:G 10/91
600:G 11/91
439:Sources
284:English
235:Sources
140:of the
80:Claims
3570:G 1/21
3562:G 1/19
3541:G 2/19
3533:G 1/15
3505:G 1/13
3501:G 1/12
3493:G 1/11
3485:G 1/10
3477:G 2/10
3469:G 1/09
3461:G 3/08
3453:G 2/08
3445:G 1/07
3408:G 2/98
3387:G 4/95
3383:G 2/93
3378:G 9/93
3357:G 1/84
3233:states
3209:Turkey
3199:Sweden
3179:Serbia
3159:Poland
3154:Norway
3134:Monaco
3109:Latvia
3084:Greece
3074:France
3049:Cyprus
3017:states
2842:Appeal
2799:Organs
2639:20 May
2486:
2370:G 9/91
2358:G 1/91
2346:G 1/91
2272:G 1/24
2254:G 1/23
2202:under
2191:G 2/22
2187:G 1/22
2155:G 2/21
2130:G 1/21
2098:G 4/19
2077:G 1/19
2065:G 2/13
2061:G 2/12
2038:G 3/19
1969:under
1965:(1) A
1958:G 2/19
1912:G 1/18
1895:G 1/03
1877:G 1/16
1851:G 1/15
1787:G 1/14
1734:G 2/13
1730:G 2/12
1706:G 3/14
1663:G 1/13
1643:G 1/12
1618:G 1/11
1591:G 1/10
1564:G 2/10
1544:G 1/08
1540:G 2/07
1508:G 1/09
1491:G 3/08
1464:G 2/08
1447:G 4/08
1427:G 1/07
1371:G 2/06
1349:G 1/06
1345:G 1/05
1309:G 1/04
1291:G 2/04
1267:G 3/03
1225:G 2/02
1201:G 2/03
1197:G 1/03
1170:G 2/98
1153:G 3/99
1132:G 1/99
1108:G 4/98
1084:G 3/98
1041:G 1/98
1016:G 1/97
995:G 4/97
991:G 3/97
971:G 7/95
967:G 1/95
950:G 8/95
918:G 4/95
855:G 1/94
838:G 2/93
807:G 4/93
803:G 9/92
776:G 3/92
756:G 1/84
747:G 9/93
730:G 1/93
713:G 4/92
645:G 9/91
620:G 1/92
596:G 3/89
576:G 8/91
572:G 7/91
551:G 5/91
519:G 1/91
492:G 8/88
488:G 7/88
484:G 5/88
450:G 2/89
446:G 1/89
398:G 6/88
381:G 2/88
364:G 4/88
328:G 1/86
317:G 9/93
308:G 1/84
288:French
280:German
266:G 7/83
262:G 6/83
258:G 5/83
254:G 4/83
250:G 3/83
246:G 2/83
242:G 1/83
174:under
3194:Spain
3129:Malta
3104:Italy
2476:(PDF)
198:Keys:
3515:and
2934:Fees
2712:2021
2641:2020
2615:2019
2589:2017
2552:2015
2526:2015
2484:ISSN
2063:and
2052:and
1989:Haar
501:DPMA
468:and
286:and
3568:),
3539:),
3519:),
3499:),
3491:),
3483:),
3475:),
3467:),
3459:),
3451:),
3422:),
3414:),
3283:(V)
3275:(V)
3267:(V)
3259:(V)
3251:(V)
3243:(E)
3231:(V)
3227:and
3225:(E)
2685:113
2323:EPC
2207:EPC
2142:EPC
2057:EPC
2050:EPC
1985:EPC
1974:EPC
1891:EPC
1864:EPC
1799:EPC
1777:."
1775:EPC
1746:EPC
1718:EPC
1631:EPC
1603:EPC
1576:EPC
1528:EPC
1521:EPC
1476:EPC
1390:EPC
1321:EPC
1279:EPC
1185:EPC
1120:EPC
1096:EPC
930:EPC
788:EPC
538:EPC
531:EPC
351:EPC
340:EPC
179:EPC
168:EPC
157:EPC
150:EPC
3592::
3531:,
3527:,
3523:,
3507:,
3503:,
3385:,
2702:.
2670:^
2649:^
2631:.
2605:.
2572:^
2542:.
2517:.
2478:.
2426:ii
2410:^
2088:.
2067:.
1897:.
1530:.
1392:.
1385:,
825:)
766:.
464:-
460:-
411:)
292:)
282:,
181:.
3576:)
3572:(
3564:(
3547:)
3543:(
3535:(
3511:(
3495:(
3487:(
3479:(
3471:(
3463:(
3455:(
3447:(
3430:)
3426:(
3418:(
3410:(
3393:)
3389:(
3363:)
3359:(
3353:)
3349:(
3317:e
3310:t
3303:v
2763:e
2756:t
2749:v
2714:.
2643:.
2617:.
2591:.
2554:.
2528:.
2490:.
2430:e
2428:.
1980:(
821:(
694:.
407:(
123:e
116:t
109:v
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.